Literature DB >> 16177274

The factorial structure of the schedule for the deficit syndrome in schizophrenia.

David Kimhy1, Scott Yale, Raymond R Goetz, Lynn Marcinko McFarr, Dolores Malaspina.   

Abstract

Deficit schizophrenia (DS) is considered a distinct subtype within the diagnosis of schizophrenia. While the common assumption is that DS represents a single, cohesive domain of psychopathology, the factorial structure of DS has not been investigated. We assessed 52 individuals with DSM-IV diagnoses of schizophrenia with DS. A principal component analysis (PCA) was conducted on the symptoms of the Schedule for the Deficit Syndrome. The PCA resulted in 2 distinct factors explaining 73.8% of the variance. Factor 1 (avolition) is made up of symptoms of curbing of interests, diminished sense of purpose, and diminished social drive. Factor 2 (emotional expression) is made up of symptoms of restricted affect, diminished emotional range, and poverty of speech. The results indicate that DS is best characterized by these 2 factors. The great majority of participants (86%) displayed DS symptoms from both factors. On average, participants had 4.19 (S.D. = 1.39) symptoms that were primary, enduring, and at least moderate in severity. The mean severity of symptoms was 2.25 (S.D. = 1.06). We discuss possible links between the obtained factors and putative neurobiological mechanisms, as well as directions for future research.

Entities:  

Mesh:

Year:  2005        PMID: 16177274      PMCID: PMC2632208          DOI: 10.1093/schbul/sbi064

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  32 in total

1.  Neocortical modulation of the amygdala response to fearful stimuli.

Authors:  Ahmad R Hariri; Venkata S Mattay; Alessandro Tessitore; Francesco Fera; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2003-03-15       Impact factor: 13.382

2.  Functional imaging of memory retrieval in deficit vs nondeficit schizophrenia.

Authors:  S Heckers; D Goff; D L Schacter; C R Savage; A J Fischman; N M Alpert; S L Rauch
Journal:  Arch Gen Psychiatry       Date:  1999-12

3.  Odor identification, eye tracking and deficit syndrome schizophrenia.

Authors:  Dolores Malaspina; Eliza Coleman; Raymond R Goetz; Jill Harkavy-Friedman; Cheryl Corcoran; Xavier Amador; Scott Yale; Jack M Gorman
Journal:  Biol Psychiatry       Date:  2002-05-15       Impact factor: 13.382

Review 4.  The cognitive control of emotion.

Authors:  Kevin N Ochsner; James J Gross
Journal:  Trends Cogn Sci       Date:  2005-05       Impact factor: 20.229

5.  Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task.

Authors:  A C Lahti; H H Holcomb; D R Medoff; M A Weiler; C A Tamminga; W T Carpenter
Journal:  Am J Psychiatry       Date:  2001-11       Impact factor: 18.112

6.  Family characteristics of deficit and nondeficit schizophrenia in the Roscommon Family Study.

Authors:  B Kirkpatrick; D E Ross; D Walsh; L Karkowski; K S Kendler
Journal:  Schizophr Res       Date:  2000-09-29       Impact factor: 4.939

7.  Regional cerebral blood flow in deficit/nondeficit types of schizophrenia according to SDS criteria.

Authors:  Guillaume Vaiva; Olivier Cottencin; Pierre Michel Llorca; Patrick Devos; Sylvie Dupont; Olivier Mazas; Claire Rascle; Pierre Thomas; Marc Steinling; Michel Goudemand
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2002-04       Impact factor: 5.067

8.  Risk factors for the deficit syndrome of schizophrenia.

Authors:  B Kirkpatrick; D Castle; R M Murray; W T Carpenter
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

Review 9.  A separate disease within the syndrome of schizophrenia.

Authors:  B Kirkpatrick; R W Buchanan; D E Ross; W T Carpenter
Journal:  Arch Gen Psychiatry       Date:  2001-02

10.  Olfaction and social drive in schizophrenia.

Authors:  Dolores Malaspina; Eliza Coleman
Journal:  Arch Gen Psychiatry       Date:  2003-06
View more
  36 in total

1.  Are Negative Symptoms Dimensional or Categorical? Detection and Validation of Deficit Schizophrenia With Taxometric and Latent Variable Mixture Models.

Authors:  Anthony O Ahmed; Gregory P Strauss; Robert W Buchanan; Brian Kirkpatrick; William T Carpenter
Journal:  Schizophr Bull       Date:  2014-11-14       Impact factor: 9.306

Review 2.  Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions.

Authors:  Deanna M Barch; Erin C Dowd
Journal:  Schizophr Bull       Date:  2010-06-21       Impact factor: 9.306

Review 3.  Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research.

Authors:  Julie W Messinger; Fabien Trémeau; Daniel Antonius; Erika Mendelsohn; Vasthie Prudent; Arielle D Stanford; Dolores Malaspina
Journal:  Clin Psychol Rev       Date:  2010-09-18

Review 4.  Subdomains within the negative symptoms of schizophrenia: commentary.

Authors:  Brian Kirkpatrick; Bernard Fischer
Journal:  Schizophr Bull       Date:  2006-02-21       Impact factor: 9.306

5.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

6.  Confirmatory factor analysis of the quality of life scale and new proposed factor structure for the quality of life scale-revised.

Authors:  Kim T Mueser; Min Kim; Jean Addington; Susan R McGurk; Sarah I Pratt; Donald E Addington
Journal:  Schizophr Res       Date:  2016-10-15       Impact factor: 4.939

7.  Characterization of the deficit syndrome in drug-naive schizophrenia patients: the role of spontaneous movement disorders and neurological soft signs.

Authors:  Victor Peralta; Lucía Moreno-Izco; Ana Sanchez-Torres; Elena García de Jalón; Maria S Campos; Manuel J Cuesta
Journal:  Schizophr Bull       Date:  2012-12-18       Impact factor: 9.306

8.  Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome.

Authors:  Gregory P Strauss; William P Horan; Brian Kirkpatrick; Bernard A Fischer; William R Keller; Pinar Miski; Robert W Buchanan; Michael F Green; William T Carpenter
Journal:  J Psychiatr Res       Date:  2013-02-27       Impact factor: 4.791

Review 9.  The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs.

Authors:  Ann M Kring; Deanna M Barch
Journal:  Eur Neuropsychopharmacol       Date:  2014-01-22       Impact factor: 4.600

10.  Factor structure of the Brief Negative Symptom Scale.

Authors:  Gregory P Strauss; L Elliot Hong; James M Gold; Robert W Buchanan; Robert P McMahon; William R Keller; Bernard A Fischer; Lauren T Catalano; Adam J Culbreth; William T Carpenter; Brian Kirkpatrick
Journal:  Schizophr Res       Date:  2012-10-09       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.